Resources
46 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 11/24/2021 (updated 3/26/2024)
This webinar will provide participants with an understanding of the role of the medical examiners and coroners in the surveillance of drug overdose deaths, as well as the current efforts to strengthen the death investigation system. The webinar will also cover an overview of the overdose fatality review process and tools available for implementation.
Posted 11/30/2021 (updated 3/26/2024)
Peer providers are viable, evidence based, stand alone or additions to comprehensive teams that approach struggle interventions. Peer providers can be appropriate for any environment that have people with challenges ranging from substance use, gun violence, domestic violence to mental health experiences.
Learning Objectives:
What are the certifications that a peer provider can receive? You will walk away knowing various ways peers can show up in the workplace.
What additional training do peer providers need? Information on what trainings would be helpful for peers to be able to support others well will be provided.
How do we find, support and retain peer providers in the work place? Knowing where to recruit peers, how to keep the workplace well for peer will be knowledge you will leave with.
Presenter: Tanya Kraege
Posted 3/3/2022 (updated 3/26/2024)
The US overdose crisis is driven by fentanyl, heroin, and prescription opioids. One evidence-based policy response has been to broaden naloxone distribution, but how much naloxone a community would need to reduce the incidence of fatal overdose is unclear. We aimed to estimate state-level US naloxone need in 2017 across three main naloxone access points (community-based programs, provider prescription, and pharmacy-initiated distribution) and by dominant opioid epidemic type (fentanyl, heroin, and prescription opioid).
Posted 3/3/2022 (updated 3/26/2024)
Drug overdose is a nationwide epidemic that claimed the lives of over 100,000 people in the United States in the past year. Opioids, either alone or in combination with other drugs or alcohol, were responsible for approximately 70 percent of these deaths. Many of those 70,000 people would be alive today if they had been administered the opioid antagonist naloxone and, where needed, other emergency care.
Posted 3/16/2022 (updated 3/27/2024)
Background: Sharp exacerbations of the US overdose crisis are linked to polysubstance use of synthetic compounds. Xylazine is a veterinary tranquilizer, long noted in the street opioid supply of Puerto Rico, and more recently Philadelphia. Yet its national trends, geographic distribution, and health risks are poorly characterized. Methods: In this sequential mixed-methods study, xylazine was increasingly observed by ethnographers in Philadelphia among drug-sellers and people who inject drugs (PWID). Subsequently, we systematically searched for records describing xylazine-present overdose mortality across the US and assessed time trends and overlap with other drugs
Posted 3/22/2022 (updated 3/27/2024)
Yesterday, the Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), is announcing two grant programs totaling $25.6 million that will expand access to medication-assisted treatment for opioid use disorder and prevent the misuse of prescription drugs. By reducing barriers to accessing the most effective, evidenced-based treatments, this funding reflects the priorities of HHS' Overdose Prevention Strategy, as well as its new initiative to strengthen the nation's mental health and crisis care systems.
Posted 6/10/2022 (updated 3/27/2024)
During this session, we discussed what meaningful inclusion is (and is not) and we offered tangible steps toward developing trust, dignity, and inclusion of PWUDs. Meeting people where they are requires an element of internal self-reflection and honesty, both personally and within the organization.
Posted 5/4/2022 (updated 3/27/2024)
Data supporting the positive outcomes associated with peer support integration throughout the substance use disorder continuum of intervention and care has led nationally to systems integrating members of this relatively new workforce into their teams. Among most peer certifying authorities, sustained recovery from substance use disorder is one of the requirements to become a peer. Although substance use recurrence or “relapse” is not common among those in sustained recovery, it does happen. This webinar will introduce suggested considerations when attempting to draft model recurrence policy for peer support employers.
Posted 8/2/2022 (updated 3/27/2024)
A new brief from the National Center for Health Statistics gives geographic detail on the latest increase in overdose death rates. Overall, urban counties had higher rates, but eight states – California, Connecticut, Maryland, New York, North Carolina, North Dakota, Vermont, and Virginia – had rates that were higher in rural counties.
Posted 8/17/2022 (updated 3/27/2024)
This presentation will detail the efforts behind the grant to develop a Recovery Friendly Workplace credential through training, technical assistance, and support that assists businesses in fostering a workplace culture that promotes employee safety, health, and well-being.